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Abstract
Background: Approximately 50% of smokers die prematurely from tobacco-related diseases. In July 2006, the
Massachusetts health care reform law mandated tobacco cessation coverage for the Massachusetts Medicaid population.
The new benefit included behavioral counseling and all medications approved for tobacco cessation treatment by the U.S.
Food and Drug Administration (FDA). Between July 1, 2006 and December 31, 2008, a total of 70,140 unique Massachusetts
Medicaid subscribers used the newly available benefit, which is approximately 37% of all Massachusetts Medicaid smokers.
Given the high utilization rate, the objective of this study is to determine if smoking prevalence decreased significantly after
the initiation of tobacco cessation coverage.
Methods and Findings: Smoking prevalence was evaluated pre- to post-benefit using 1999 through 2008 data from the
Massachusetts Behavioral Risk Factor Survey (BRFSS). The crude smoking rate decreased from 38.3% (95% C.I. 33.6%–42.9%)
in the pre-benefit period compared to 28.3% (95% C.I.: 24.0%–32.7%) in the post-benefit period, representing a decline of 26
percent. A demographically adjusted smoking rate showed a similar decrease in the post-benefit period. Trend analyses
reflected prevalence decreases that accrued over time. Specifically, a joinpoint analysis of smoking prevalence among
Massachusetts Medicaid benefit-eligible members (age 18–64) from 1999 through 2008 found a decreasing trend that was
coincident with the implementation of the benefit. Finally, a logistic regression that controlled for demographic factors also
showed that the trend in smoking decreased significantly from July 1, 2006 to December 31, 2008.
Conclusion: These findings suggest that a tobacco cessation benefit that includes coverage for medications and behavioral
treatments, has few barriers to access, and involves broad promotion can significantly reduce smoking prevalence.
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Introduction
Cigarette smoking continues to be the leading cause of
preventable morbidity and mortality in the United States [1].
Despite recent overall declines in smoking prevalence in the
United States, the prevalence in the Medicaid population – the
health insurance program for the poor - has remained 65% higher
than in the rest of the population [2,3]. In Massachusetts alone,
smoking causes $1 billion annually in excess health care costs to
the Medicaid program. In April 2006, the Massachusetts
legislature passed Chapter 58 of the Acts of 2006 (‘‘An Act
Providing Access to Affordable, Quality, Accountable Health
Care’’) requiring all individuals in Massachusetts to have health
insurance. In an effort to reduce smoking prevalence in the
Medicaid population, the law mandated coverage for two types of
tobacco cessation treatment: behavioral counseling and all Food
and Drug Administration (FDA)-approved medications. Prior to
2006, MassHealth (the Massachusetts Medicaid program) did not
provide tobacco cessation benefits.
With the implementation of this benefit, MassHealth subscrib-
ers are allowed two 90-day courses per year of FDA-approved
medications for smoking cessation, including OTC medications
like nicotine replacement therapy, and up to 16 individual or
group counseling sessions. Medications require written prescrip-
tions following an office visit. Prior authorization is not required to
prescribe the nicotine patch, gum, lozenge, Chantix, or bupropi-
on/Wellbutrin. With prior authorization, the nicotine inhaler and
nasal spray may also be covered. The co-payment is minimal at
$1.00 or $3.00. Detailed information on the benefit design and
reimbursement rates is available at www.makesmokinghistory.
org/quitworks/masshealth.html. A total of 70,140 unique Mas-
sHealth subscribers used the newly available benefit between July
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e97701, 2006 and December 31, 2008, i.e., approximately 37% of all
Medicaid smokers. All utilization data reported in this paper were
obtained from MassHealth claims data.
It is the objective of this study to determine if smoking
prevalence decreased in the Massachusetts Medicaid population
after the initiation of mandated tobacco cessation coverage.
Methods
Data Source
The Behavioral Risk Factor Surveillance System (BRFSS) is the
largest continuously conducted telephone health surveillance
system of adults in the world [4]. The BRFSS is a state-based,
cross-sectional telephone survey conducted by state health
departments with technical and methodological assistance provid-
ed by the Centers for Disease Control and Prevention (CDC).
BFRSS surveys focus data collection on behaviors, in contrast to
attitudes or knowledge. States use BRFSS data to identify
emerging health problems, establish health objectives, and track
their progress toward meeting these objectives [4].
Main Outcome Measures
Although the BRFSS covers a wide variety of questions about
health behaviors, this work focuses on responses to questions about
tobacco use. Smoking status is divided into three groups: current
smokers, former smokers, and never smokers. Current smokers are
defined as having smoked at least 100 cigarettes in their lifetimes
and smoke currently. Former smokers are defined as having
smoked at least 100 cigarettes in their lifetimes but did not smoke
currently. Individuals who have not smoked at least 100 cigarettes
in their lifetimes were classified as never smokers. Quit attempts
were measured by counting individuals who had stopped smoking
for 1 day or more during the preceding 12 months in an attempt to
quit. Recent quits were counted using individuals who had stopped
smoking within the previous 12 months.
Other Variables of Interest
Unlike most states, the Massachusetts BFRSS includes health
insurance questions. These questions make it possible to distinguish
respondents by insurance status including coverage by MassHealth.
Because the MassHealth tobacco cessation benefit was limited to
subscribers between the ages of 18–64, this study was also limited to
MassHealth subscribers ages 18–64. Approximately one in six (16%)
Massachusetts BRFSS survey respondents identify their health
insurance as MassHealth, the Massachusetts Medicaid program.
Statistical Analysis
This study is fundamentally ecological in nature; therefore, it
was not possible to link specific utilization behavior with individual
quits or quit attempts. Consequently, this analysis will look at the
available BRFSS data from three perspectives in order to provide
greater confidence in the results reported. Tests of proportional
differences were followed by a trend analysis which was followed
by logistic regression.
At the most basic level, differences in proportions were
evaluated using t-tests. Since health care reform legislation in
Massachusetts expanded eligibility for the MassHealth program,
difference estimates were computed for population samples that
were adjusted for demographic changes in the post-benefit period.
Demographically-adjusted rates were calculated in such a way that
the demographic characteristics of the post-benefit period (July 1,
2006 – December 31, 2008) were forced to match those in a
specified pre-benefit period (January 1, 2003 – June 2006).
Adjustments were made for age, gender, education, and race/
ethnicity. Age was grouped into 5 categories: 18–24, 25–34,
35–44, 45–54, and 55–64 year olds. Education status was classified
as (1) less than a high school education, (2) high school graduate or
GED, (3) 1 to 3 years of college, or (4) 4+ years of college. Race/
ethnicity was categorized as (1) white, non-Hispanic or (2) other.
For all tests of proportional differences, the sample population
used in the pre-benefit period included only MassHealth
subscribers despite an increase in MassHealth enrollment post-
benefit. By December 2008, the number of adults covered by
MassHealth increased by 11.3% when compared to 2006 levels. A
2009 Kaiser Commission study estimated that 76,000 previously
uninsured adults received coverage through MassHealth by
December 2008 [5]. Since the increased enrollment in Mas-
sHealth was only slightly higher than the 76,000 estimated by
Kaiser, it would be tempting to include all uninsured adults in any
analysis of the pre-benefit period. However, the Kaiser report also
estimates that more than four times as many previously uninsured
adults (354,000) obtained insurance coverage through other
programs. The majority obtained private health insurance or
used the state’s subsidized insurance program (Commonwealth
Care). As a result, including uninsured adults in the pre-benefit
population would likely overestimate the impact of the uninsured
within the total MassHealth population.
In addition to tests of proportions involving smoking prevalence,
quit attempts as well as the success of those attempts also were
examined. It was hypothesized that a result indicating a decrease in
smoking prevalence that was coincident with the implementation of
the MassHealth tobacco cessation benefit could occur for two
reasons. First, more smokers could be making quit attempts. Or
second, more smokers could be making successful quit attempts.
Trend analyses were computed using joinpoint analysis. The
National Cancer Institute publishes joinpoint analysis software as a
tool for assessing public health trends. More information on
joinpoint analysis is available at the National Cancer Institute
website at http://srab.cancer.gov/joinpoint/. The joinpoint soft-
ware takes trend data and fits the simplest joinpoint model that the
data will allow.No minimum or maximum joinpointswere specified
for the models used in this analysis, thereby allowing the joinpoint
software to select the most appropriate model for the data. The
basic data element of the joinpoint analysis was a demographically-
adjusted smoking prevalence estimate. These were computed for
each six month period between 1999 and 2008.
Compared to the analysis of differences in proportions described
above, a longer time period was used for the joinpoint analysis.
This decision was made because a shorter time period would have
reduced the likelihood of finding multiple joinpoints in the pre-
benefit period. It was considered important to know whether post-
benefit smoking prevalence levels in the MassHealth population
had been matched in some earlier period. A longer time period
increased the likelihood of seeing trends that would contradict the
hypothesis that decreased prevalence might be attributed to the
initiation of cessation coverage.
Finally, a logistic regression was computed so as to make
individual level adjustments for demographics. Here, the target
variable was current smoking status as recorded by the BRFSS. In
addition to demographic variables, two more variables were added
to the logistic model to assess trends. First, a monthly sequential
variable from January 1999 to December 2008 was included. This
was used to measure long-terms trends in prevalence. Second, a
monthly sequential variable beginning in July 2006 and ending
December 2008 was also included to capture trends that were
limited to the post-benefit period. The demographic variables used
in the analysis were gender, race/ethnicity, education status, and
age which could account for changes in demographics.
MassHealth Tobacco Treatment
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BRFSS data are directly weighted for the probability of selection
of a telephone number, the number of adults in a household, and
the number of telephones in a household. A final post-stratification
adjustment is made for non-response and non-coverage of
households without telephones. The weights for each factor are
multiplied together to get a final weight. All reported estimates
were weighted using statistical analysis software (SAS version 9.1).
The a priori significance level used for statistical tests was 0.05.
Results
Smoking prevalence was examined in the MassHealth popula-
tion from 1999 through 2008 using the Behavioral Risk Factor
Surveillance System (BRFSS). The number of BRFSS respondents
who were eligible for the benefit (i.e., MassHealth members aged
18 to 64) ranged from 402 respondents in 1999 to 1,969
respondents in 2008. Depending on the specific analysis, different
time periods were studied.
It should be noted that the BRFSS relies on self-reports including
questions about insurance status. To test the accuracy of self-reports
about insurance, Massachusetts conducted a call-back survey with a
subset of BRFSS respondents in 2007. The second call to the
respondent took place an average of 31 days after the first call. The
call-back survey found that more than 90% of respondents who had
previouslyindicatedthattheyhad MassHealthcoverage wereableto
confirm the presence of a valid MassHealth logo on their insurance
card. The 2007 call-back survey suggests that the reliability of self-
reported MassHealth subscriber status is high. (Source: Unpublished
results of Massachusetts BRFSS 2007 follow-up interviews)
The unadjusted or crude estimate of smoking prevalence was
significantly higher in the pre-benefit period when compared to
Table 1. Comparison of Pre-, Post-Benefit Periods on Smoking Prevalence And Quitting Behavior.
Pre-Benefit Period January 1, 2003
to June 30, 2006
Post-Benefit Period January 1, 2008
to December 31, 2008
Measure Crude% 95% C.I. Crude % 95% C.I. Dem-Adj % 95% C.I.
Current smoking 38.3 33.6 – 42.9 28.3* 24.0–32.7 28.8* 24.3 – 33.3
Quit Attempt 62.6 55.9 – 69.4 67.2 59.6 – 74.8 67.6 60.5 – 74.7
Recent Quit Success 6.6 3.8 – 9.3 18.9* 10.2 – 27.7 19.1* 13.0 – 25.2
*Statistically significant at the .05 level.
Data Source: BRFSS 2003 – 2008.
doi:10.1371/journal.pone.0009770.t001
Table 2. Demographics for the MassHealth Population, Age 18–64 for the Pre- and Post- Benefit Periods with Crude Smoking
Rates.
Pre-Benefit Period January 1, 2003 to June 30, 2006
Post-Benefit Period January 1, 2008 to December 31,
2008
Characteristic
Sample
Size
Weighted
Sample Size %
Crude Smoking
(%)
Sample
Size
Weighted
Sample Size %
Crude Smoking
(%)
% Change
in Smoking
Overall Population 2,016 892,919 100 38.3 1,969 454,851 100 28.3* 226%
Gender
Male 414 264,897 29.7 41.8 561 174,919 38.5* 28.4 232%
Female 1,602 628,022 70.3 36.8 1,408 279,931 61.5* 28.3 223%
Age
18–24 295 265,878 29.8 38.1 214 132,809 29.2 22.6 241%
25–34 550 241,466 27.0 42.9 377 97,685 21.5 33.8 221%
35–44 530 212,151 23.8 35.7 427 80,245 17.6* 34.4 24%
45–54 383 107,135 12.0 42.6 534 91,774 20.2* 31.0* 227%
55–64 258 66,289 7.4 23.2 417 52,338 11.5* 18.5 220%
Education status
, HS 534 155,736 24.9 36.1 441 61,627 19.2 39.6 +10%
HS graduate 604 232,242 37.1 43.0 582 107,146 33.4 31.7 226%
College 1–3 years 389 155,035 24.8 42.1 411 81,309 25.4 31.2 226%
College 4+ years 192 82,618 13.2 22.9 312 70,632 22.0* 20.1 212%
Race/ethnicity
White, non-Hispanic 970 477,377 53.9 51.5 1,036 266,608 58.8 33.0* 236%
Other 1,025 408,022 46.1 22.7 918 186,676 41.2 21.7 24%
*Statistically significant at the .05 level.
Data Source: BRFSS 2003 – 2008.
doi:10.1371/journal.pone.0009770.t002
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between 1/1/2003 and 6/30/2006 for MassHealth members
18–64 was estimated to be 38.3% (95% C.I. 33.6%–42.9%). In
calendar year 2008, the most recently available data, pre-
valence for this population was estimated to be 28.3% (95% C.I.:
24.0%–32.7%). The above analyses were not adjusted for
demographic changes in the post-benefit population.
Two comparisons were made with the demographically
adjusted rates. First, the demographically adjusted rates were
compared to the unadjusted rates for the post-benefit period.
Here, there were no significant differences between the adjusted
and unadjusted rates for current smoking prevalence, percentage
of smoker making quit attempts, and recent quit success. See
Table 1 for details. The absence of significant differences suggests
that the effects of demographic changes in the MassHealth
population with respect to smoking behavior were minimal.
Given the above result, comparisons also were made for
smoking behavior between the pre-benefit period and post-benefit
period using the demographically adjusted rates. As shown in
Table 1, there were significant differences in the rate of current
smoking (38.3% pre-benefit vs. 28.8% post-benefit) and recent quit
success (6.6% pre-benefit vs. 19.1% post-benefit) using the
demographically adjusted data. There were no differences for
the percentage of smokers making quit attempts. For a full
breakdown of the demographics for the pre-benefit period
compared to the post-benefit period, see Table 2.
Joinpoint trend analyses were computed for smoking prevalence
between 1999 and 2008. Since information about quit success was
not asked in every year, trend analyses were not computed for quit
success. Results showed that a model with one joinpoint was the
best fit for prevalence estimates between 1999 through 2008. The
sole joinpoint corresponded precisely with the implementation of
the MassHealth tobacco cessation benefit (see Figure 1). Prior to
July 2006, there was no significant change in smoking prevalence
among the MassHealth population. Beginning in July 2006,
demographically adjusted smoking prevalence dropped at an
annual rate of 15.2% (see Table 3).
Finally, in order to make individual level adjustments for
demographics, a logistic regression was computed. The target
variable was current smoking as recorded by the BRFSS. Two
time variables were included in this analysis: a long-term trend
variable and one that would measure changes in the post-benefit
Figure 1. Demographic-Adjusted Smoking Prevalence of MassHealth Members, Age 18–64, 1999 to 2008 (Joinpoint Trend). (1) The
diamonds on the chart represent the 6-month smoking prevalence estimates based on responses to the BRFSS. Initial weighting of prevalence
estimates used a standard BRFSS weighting scheme in which data are directly weighted for the probability of selection of a telephone number, the
number of adults in a household, and the number of telephones in a household. A final post-stratification adjustment is made for non-response and
non-coverage of households without telephones. Data were also weighted in such a way to force prevalence estimates to match demographic
characteristics for the period from 1/1/2003 through 6/30/2006. (2) The lines on the chart represent the smoking prevalence trends for the
MassHealth population as estimated by the joinpoint analysis. The period between 1/1/1999 and 6/30/2006 showed no significant change (p=0.93).
Beginning 7/1/2006, there was a significant downward trend (p,0.05).
doi:10.1371/journal.pone.0009770.g001
MassHealth Tobacco Treatment
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9770period only. Demographic adjusters were also included. The long-
term trend in smoking prevalence over the entire time period
(1999 through 2008) was non-significant (p=0.60). However, the
trend in the post-benefit period showed a significant decrease
(p,.001) with an estimated annual decrease of 15.0% per year.
See Table 4 for details.
Discussion
The Massachusetts experience suggests that a good benefit
design, combined with broad promotion, can result in a significant
reduction in smoking prevalence. In the past 20 years, dramatic
reductions occurred in smoking prevalence among the college
educated in Massachusetts. These results suggest that when offered
easy access to low-cost medications, the Medicaid population can
also show significant reductions in smoking prevalence. Further-
more, there was a significant increase in quit success without any
corresponding increase in the proportion of smokers making quit
attempts. Further research is required to determine the role of
promotion in the decrease in smoking prevalence in this
population. Data was not available in the Massachusetts BRFSS
to determine whether there was any increase in evidence-based
quit attempts in the post-benefit period.
Several limitations should be noted. Smoking prevalence might
be increasingly underestimated by BRFSS traditional survey
method because adults lacking landlines are more likely than the
general population to smoke [6]. However, systematic bias
introduced by declining response rates or the ongoing trend away
from landlines would have been gradual. In contrast, the joinpoint
analysis and logistic regression suggest a sharp change in smoking
prevalence trend. Estimates of smoking prevalence were based on
self-report, but self-reported smoking status has been shown to
have high validity [7].
Also, enrollment in MassHealth increased following health
reform. While much of this increase may have come from the rolls
of the previously uninsured, most uninsured found insurance
through other programs [6]. Responses to the BRFSS did not
include questions about the length of time one was insured
through any particular insurer, therefore it cannot be precisely
determined how much the increased enrollment affected preva-
lence estimates. To partially account for these demographic
changes resulting from enrollment increases, prevalence estimates
were computed using a weighting scheme that forced the
demographic characteristics of the post-benefit period to match
those in the pre-benefit period.
Finally, smoking cessation was promoted broadly to the full
Massachusetts population in several ways during the study time
period. For example, MTCP ran a general media campaign
November 2007 – January 2008; pharmaceutical companies
advertised products for cessation; and on July 1, 2008, the state
excise tax increased by $1 per pack and the state quitline began
offering free nicotine patches to callers. The proportion of
MassHealth subscribers among quitline callers did not change
between 2005 and 2008. Thus, it seems unlikely that broad-based
actions such as advertising, as opposed to the tobacco cessation
treatment itself, are the primary explanations for MassHealth
subscribers’ higher quit rate over the last 2 years.
Information comparable to that reported here for Massachusetts
has not been published for other states or the U.S. as a whole. The
crucial health implications of preliminary findings from Massa-
chusetts strongly suggest that similar analyses be undertaken in
other states. Variations across states in level of benefits, ease of
access to services, extent of advertising and other promotion of
benefits, and baseline smoking prevalence provide opportunities
for comparative analyses that could help identify variables that
foster the largest possible impacts of benefits. Subsequent research
might focus on linking drops in smoking prevalence to improved
health outcomes, reduction in claims, and specific cost-contain-
ment strategies.
The Public Health Service’s Clinical Practice Guideline for
treating tobacco use and dependence recommends that both
Table 3. Demographic-Adjusted Smoking Prevalence for
Joinpoint Analysis, 1999–2008.
Six Month
Period
Demographic-Adjusted
Smoking Prevalence
Joinpoint
Predicted Value
Estimate Standard Error
1 32.2% 5.4% 41.42%
2 38.1% 4.7% 41.39%
3 40.0% 4.4% 41.37%
4 35.7% 4.1% 41.35%
5 48.2% 4.0% 41.33%
6 43.6% 1.8% 41.30%
7 39.1% 4.0% 41.28%
8 38.1% 4.0% 41.26%
9 31.5% 4.0% 41.24%
10 50.6% 7.7% 41.21%
11 41.8% 7.7% 41.19%
12 37.1% 5.1% 41.17%
13 37.4% 5.1% 41.15%
14 41.4% 1.6% 41.12%
15 (Joinpoint 1) 40.7% 3.7% 41.10%
16 34.3% 3.7% 37.97%
17 36.7% 3.0% 35.08%
18 33.1% 2.2% 32.40%
19 30.4% 2.4% 29.93%
20 25.5% 3.0% 27.65%
Data Source: BRFSS 1999 – 2008.
doi:10.1371/journal.pone.0009770.t003
Table 4. Logistic Regression on Smoking Prevalence with
Trend and Demographic Independent Variables, 1999–2008.
Parameter Estimate
Odds
Ratio
Pr .
ChiSq
Overall Trend (monthly) 0.000582 1.001 0.60
Post-Benefit Trend (monthly) 20.0135 0.987 0.0004
Age 20.0128 0.987 ,.0001
Gender
N Male vs. Female (ref.) 0.0554 1.117 0.06
Race/ethnicity
N White vs. non-White (ref.) 0.5608 3.070 ,.0001
Education
N , HS vs. 4+ years of college (ref.)
N HS vs. 4+ years of college (ref.)
N Some college vs. 4+ years (ref.)
0.5190
0.2500
0.0649
3.868
2.956
2.956
,.0001
,.0001
,.0001
Data Source: BRFSS 1999 – 2008.
doi:10.1371/journal.pone.0009770.t004
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offering cessation services is an integral part of the World Health
Organization’s MPOWER policy package for reversing the
tobacco epidemic [9]. The Massachusetts tobacco cessation benefit
claims utilization data are, by inspection, suggestive that
pharmacotherapy treatments might be particularly promising in
terms of probability of being utilized. One possible reason why
cessation counseling was little used by MassHealth subscribers is
that relatively few primary care settings had the staff resources
needed to make 30- or 60-minute tobacco treatment sessions
readily available. Although speculative, it seems likely that many
office encounters leading to prescriptions for tobacco cessation
medications also included caregiver discussion and advice on
quitting, even if counseling was not the primary purpose of the
visit.
The Massachusetts findings suggest that a broadly-promoted,
accessible, comprehensive smoking cessation benefit can reduce
smoking prevalence in the Medicaid population. In 2004, U.S.
Medicaid expenditures for smoking-related conditions totaled $22
billion [10]. Tobacco cessation treatment is cost-effective and
should be made available to all smokers [11] via health insurance
benefits. Fully implementing known tobacco control strategies has
strong promise to end the U.S. tobacco epidemic [12].
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